Investment Foci: Biotech and Healthcare
Di Liu is a Partner at Cowin Venture, focusing on healthcare investments both in China and in the US.
Di's career in venture capital started in 2011. Before joining Cowin in 2015, she had been director at GSR Ventures and application support consultant at Roche Diagnostics. Di has led and participated in deals such as AMT Medical, Gateway Medical, Paragon Genomics, Sensulin, NeuCyte and Mirabilis Medica, etc.
Di Liu holds an MS in Biology from UPenn and a BS in biology from Tsinghua University.